Board of Directors
/
Helge Lund
Disease areas
Science & technology
Partnering
Sustainable business
Careers
About us
Our products
Patients
Investors
Healthcare professionals
News & media
Contact us
Chair of the board of directors of BP p.l.c., Inkerman AS and Stiftelsen Værekraft.
Member of the board of directors of Belron SA and P/F Tjaldur.
Operating advisor to Clayton Dubilier & Rice.
Member of the board of trustees of the International Crisis Group.
Chief executive of BG Group plc., 2015-2016.
President and CEO of Equinor ASA, 2004-2014.
President and CEO of Aker Kvaerner ASA, 2002-2004.
Considered independent under the Danish Corporate Governance Recommendations.
Member of the Board of Directors since 2017 and Chair since 2018. Most recently elected in 2024 for a term of one year.
Chair of the Chair Committee since March 2018.
Member of the People and Governance Committee (previously the Nomination Committee) since March 2017 and chair of the Committee since March 2018.
Member of the Board of Directors, 2014-2015.
Global corporate leadership.
Healthcare and pharma industry.
Finance & accounting.
Business development, M&A and external innovation sourcing.
Human capital management.
Environmental, social and governance (ESG).
1991: MBA, INSEAD, France.
1987: MA in Economics, Norwegian School of Economics & Business Administration (NHH), Norway.
Norwegian, born 1962. Male.